Xu Kecheng talks to PhD students who work as researchers in Fuda Cancer Hospital's laboratories

Part of Fuda's appeal to patients is the fact that the palliative care offered, especially immunotherapy, has the potential of extending life. Immunotherapy has become the first treatment option for diseases such as melanoma and lung cancer in some countries. But its use for palliative care is uncommon.

 

www.fudacancerhospital.org/fudanews/20160827566.html

Done